Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04357587
Title Safety and Feasibility of PD-1 Blockade in the Treatment of Rectal Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Case Comprehensive Cancer Center
Indications

rectum adenocarcinoma

Therapies

Capecitabine + Pembrolizumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.